Terminated NA INTERVENTIONAL 2-arm NCT00939042

Alster Stem Cells - Intramyocardial Stem Therapy

Percutaneous Intramyocardial Cell Therapy After Acute Myocardial Infarction Using Bone Marrow Mononuclear Cells

Sponsor: Asklepios proresearch

Conditions Acute Myocardial Infarction Early Left Ventricular Dysfunction

Interventions BMNC therapy Percutaneous Coronary Intervention

Updated 8 times since 2017 Last updated: Oct 5, 2022 Started: Jan 31, 2009 Primary completion: Jan 31, 2014 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI left institution

This NA trial investigates Acute Myocardial Infarction and Early Left Ventricular Dysfunction and is currently terminated or withdrawn. Asklepios proresearch leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Terminated NA
Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Nov 2022 — Jul 2024 [monthly]

Terminated NA
Jan 2021 — Nov 2022 [monthly]

Terminated NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated NA
May 2018 — Jun 2018 [monthly]

Terminated NA

Status: Unknown Status → Terminated · Phase: PHASE2 → NA
Jan 2017 — May 2018 [monthly]

Unknown Status PHASE2

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asklepios proresearch

Data source: Asklepios proresearch

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany